Syngenta Group Boosts EBITDA Margins Despite Revenue Dip in H1 2026 — Syngenta Group Co., Ltd.

Event summary

Syngenta Group reported H1 2026 sales of $12.2 billion, down 2% YoY (-7% at CER), driven by restructuring of low-margin grain trading in China.
EBITDA rose to $2.4 billion, up 2% YoY (+3% at CER), with EBITDA margins expanding to 19.5% from 18.6% in H1 2025.
Syngenta Crop Protection sales grew 4% YoY (-1% CER), led by strong demand for PLINAZOLIN®, ADEPIDYN®, and TYMIRIUM® technologies.
Syngenta Seeds sales increased 1% YoY (-3% CER), with Brazil delivering 18% growth in Field Crops.
ADAMA sales remained flat YoY (-3% CER), with volume growth offset by pricing pressure and strategic reduction of low-margin products in China.

The big picture

Syngenta Group’s focus on core businesses, innovation, and AI leadership is driving margin expansion despite a challenging macroeconomic environment. The strategic reduction of low-margin businesses in China and disciplined cost management are key to sustaining profitability. As the largest agricultural technology company by revenue, Syngenta’s ability to scale AI capabilities and deliver innovation will be critical in maintaining its leadership position in a competitive industry.

What we're watching

AI Integration: How Syngenta Group’s investment in AI capabilities will translate into tangible business value and operational efficiency.
Market Volatility: Whether Syngenta can sustain profitable growth amid volatile macroeconomic and geopolitical conditions under new CEO Hengde Qin.
Regional Performance: The pace at which Syngenta can recover sales in Latin America and North America, where restructuring and pricing pressures have impacted growth.